Table 2.
Frequency and Postoperative Survival of Patients with Primary Glioblastoma with Low and High Protein Expression Categories.
| Protein Expression | Number of Patients | Percentages of Patients | Median Survival Estimate (Days) | SE | 95% CI | Log-Rank Test P Value |
| Nodal | .595 | |||||
| Low (scores 0–1) | 161 | 80.9 | 241 | 26.1 | (190.0, 292.0) | |
| High (scores 2–3) | 12 | 6.0 | 285 | 13.0 | (259.5, 310.5) | |
| Missing | 26 | 13.1 | ||||
| Lefty | .162 | |||||
| Low (scores 0–1) | 174 | 87.4 | 259 | 28.2 | (203.7, 314.3) | |
| High (scores 2–3) | 2 | 1.0 | 86 | |||
| Missing | 23 | 11.6 | ||||
| Cripto-1 | .161 | |||||
| Low (scores 0–1) | 61 | 30.7 | 259 | 54.1 | (153.0, 365.1) | |
| High (scores 2–3) | 110 | 55.3 | 242 | 35.9 | (171.6, 312.4) | |
| Missing | 28 | 14.1 |
Univariate survival analyses (Kaplan-Meier method) of 199 patients operated at Haukeland University Hospital in the period from 1998 to 2008.
SE indicates standard error; CI, confidence interval.